Regarding immune evasion, PD-L1 is overexpressed in diverse EBV-related lymphomas, and therefore, strategies targeting PD-1/PD-L1 interaction are of great importance and could be a very useful target for the treatment of EBV-related HRL. This evidence concerns the gene CD274 and lymphoma.